Skip to main content
Helixmith Co., Ltd logo

Helixmith Co., Ltd — Investor Relations & Filings

Ticker · 084990 ISIN · KR7084990001 KO Manufacturing
Open in API
Filings indexed 508 across all filing types
Latest filing 2020-11-19 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 084990

About Helixmith Co., Ltd

https://www.helixmith.com/

Helixmith is a biotechnology company specializing in the research and development of gene therapies. Established in 1996, the company focuses on creating innovative biopharmaceuticals for diseases with significant unmet medical needs. Its core activities revolve around an extensive pipeline of next-generation gene therapy products. The primary therapeutic areas of focus include neurological and cardiovascular disorders, such as peripheral artery disease and coronary artery disease. Helixmith manages a comprehensive range of capabilities, from discovery and preclinical studies to clinical development of its drug candidates.

Recent filings

Filing Released Lang Actions
[기재정정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a 'Securities Registration Statement' (증권신고서) filed by Helixmith Co., Ltd. It contains detailed information regarding the issuance of securities, including amendments to investment risk factors, financial statements, and management's discussion of financial results following the submission of a quarterly report. This is a formal regulatory filing required by the Financial Supervisory Service (FSS) in South Korea for companies offering securities to the public. Since it is a comprehensive regulatory document detailing the terms of a securities offering and associated risks, it falls under the 'Regulatory Filings' category.
2020-11-19 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Helixmith' (헬릭스미스) covering the period from January 1, 2020, to September 30, 2020. It contains detailed financial data, business descriptions, capital structure, and management information, which are characteristic of an interim/quarterly financial report. It is not an announcement of a report, but the report itself. 9M 2020
2020-11-16 Korean
유상증자1차발행가액결정(주주배정후 실권주 일반공모)
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Helixmith regarding the determination of the first issue price for a paid-in capital increase (rights offering). It details the number of shares, the calculated price per share, and the methodology for determining the final issue price. This falls under the category of capital and financing updates, specifically related to share issuance and capital structure changes.
2020-11-12 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a capital increase (유상증자결정) for Helixmith Co., Ltd. It details the amendment of the capital increase plan, including changes to the purpose of funds, share issuance prices, and subscription schedules. This type of regulatory filing in the Korean DART system is specifically categorized as a 'Share Issue/Capital Change' announcement, as it pertains to the company's capital structure and issuance of new shares.
2020-11-12 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서(지분증권) 정정신고서' (Amendment to Securities Registration Statement) filed with the Financial Services Commission of South Korea. It details changes to the terms of a capital raise (rights offering), specifically updating the issue price and financial projections. In the context of the provided filing categories, this document represents a formal regulatory filing regarding capital structure and financing activities. Since it is a detailed regulatory filing rather than a simple announcement of a report, it falls under 'Regulatory Filings' (RNS) as the most appropriate fallback category for this type of official financial disclosure.
2020-11-12 Korean
투자설명서
Capital/Financing Update Classification · 95% confidence The document is a 'Securities Registration Statement' (증권신고서) for a capital increase (유상증자) by Helixmith. It contains detailed information about the offering, including the number of shares, pricing, subscription periods, and extensive risk factors related to the company's financial health, potential delisting, and management of funds. This document is a formal regulatory filing required for public offerings in South Korea (DART system). While it contains financial data, it is not an Annual Report (10-K) or an Earnings Release (ER), but rather a prospectus-style document for a capital raise. Among the provided categories, 'Regulatory Filings' (RNS) is the most appropriate fallback for this type of formal securities registration document.
2020-11-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.